D89.813 Graft-versus-host disease, unspecified

Name of the Condition

• Graft-versus-host disease, unspecified

Summary

Graft-versus-host disease (GVHD) is an immune-mediated condition that occurs when transplanted immune cells (graft) attack the recipient’s tissues (host). It typically arises after allogeneic hematopoietic stem cell transplantation but can also occur in other settings, such as blood product transfusions. The condition can affect multiple organ systems, with skin, gastrointestinal tract, and liver being the most commonly involved. Acute and chronic forms exist, distinguished by timing and clinical features. This code is used when the specific type (acute or chronic) is not documented.

Causes

GVHD is caused by donor immune cells recognizing the recipient’s tissues as foreign and mounting an immune response. In allogeneic transplantation, this occurs when the graft contains functional T cells that react against the host’s histocompatibility antigens. The risk increases with greater HLA mismatch between donor and recipient. Non-transplant-related GVHD may occur after transfusions in immunocompromised patients, where donor lymphocytes engraft and attack the host.

Risk Factors

• Allogeneic hematopoietic stem cell transplantation
• HLA mismatch between donor and recipient
• Older age of the recipient
• Female donors for male recipients (due to prior pregnancies)
• Intensity of conditioning regimens
• Use of peripheral blood stem cells (vs. bone marrow)
• Prior episodes of acute GVHD

Symptoms

Symptoms vary by organ system and may include skin rash, jaundice, abdominal pain, diarrhea, nausea, vomiting, and elevated liver enzymes. Chronic GVHD may present with additional features like dry eyes, mouth, or skin, joint stiffness, or lung involvement.

Diagnosis

Diagnosis is based on clinical presentation, history of transplantation or transfusion, and biopsy of affected tissues (e.g., skin, liver, or gut). Laboratory tests, including liver function tests and HLA typing, may support the diagnosis. Imaging or endoscopic evaluation may be used to assess organ involvement.

Treatment Options

Treatment depends on severity and may include immunosuppressive medications (e.g., corticosteroids), topical therapies for skin involvement, or systemic agents for severe cases. Supportive care, such as managing diarrhea or skin care, is also important.

Prognosis and Follow-Up

Prognosis varies by severity and organ involvement. Mild cases may resolve with treatment, while severe cases can be life-threatening. Long-term follow-up is necessary to monitor for chronic GVHD, organ damage, or secondary complications.

Complications

Complications may include organ failure (e.g., liver, lung), infections due to immunosuppression, and chronic GVHD with persistent symptoms affecting quality of life.

Lifestyle & Prevention

Prevention focuses on minimizing risk factors, such as optimizing HLA matching and using appropriate conditioning regimens. Post-transplant care, including monitoring and early intervention, helps reduce severity.

When to Seek Professional Help

Seek medical attention if symptoms worsen, new organ systems are involved, or signs of infection (e.g., fever, chills) develop. Prompt evaluation is critical for managing severe or progressive GVHD.

Tips for Medical Coders

Use this code when the specific type of graft-versus-host disease (acute or chronic) is not documented. Ensure documentation supports the diagnosis and organ involvement. Verify that the condition is not better classified under a more specific GVHD code if details are available.